CRYSELDA TREVINO: Open Payments
NPI 1982243663 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,163 in 96 payments from 22 companies in 2025. Trend: 2023 $914 · 2024 $1,690 · 2025 $2,163
Food & beverage: $2,163
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $382 |
| Amgen Inc. | 9 | $231 |
| Corcept Therapeutics | 7 | $202 |
| AstraZeneca Pharmaceuticals LP | 6 | $177 |
| Lilly USA, LLC | 8 | $155 |
| Axsome Therapeutics, Inc. | 5 | $138 |
| Novo Nordisk Inc | 7 | $136 |
| GlaxoSmithKline, LLC. | 8 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
| Merck Sharp & Dohme LLC | 1 | $102 |
Products named: Korlym, JARDIANCE, VRAYLAR, Auvelity, Repatha, CAPVAXIVE, QULIPTA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
